Notably, VSIG4 knockout enhanced the anti-tumor immunity of macrophages by increasing antigen-presentation associated ligand-receptor pairs between macrophages and CD8+ T cells (Fig. S5 A). The gene discussed is CD8A; the disease is neoplasm.